<DOC>
	<DOCNO>NCT00747474</DOCNO>
	<brief_summary>The purpose study find safe tolerable dose Lipotecan® administer patient advance solid tumor .</brief_summary>
	<brief_title>Phase I Study Intravenous Lipotecan® ( TLC388 HCl Injection ) Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>Lipotecan® drug product TLC388 HCl , potent camptothecin analog cytotoxic activity variety human tumor cell line vitro anti-tumor activity several xenograft model human tumor cell line . Structurally , TLC388 HCl relate camptothecins , chemically modify improve stability potency , minimize toxicity .</detailed_description>
	<criteria>Adult patient define age ≥18 year . Pathologically confirm advanced solid tumor standard therapy proven provide clinical benefit exist longer effective Evaluable disease , either measurable imaging informative tumor marker ( ) , RECIST ( Response Evaluation Criteria Solid Tumors ) criterion . Pregnancy lactation . Women childbearing potential must negative pregnancy test within 7 day prior enrolment . Male female patient childbearing potential must agree use appropriate birth control ( barrier method spermicide , oral parenteral contraceptive and/or intrauterine device ) entire duration study , patient must surgically sterile ( documentation patient 's medical record ) . Previous malignancy , except nonbasalcell carcinoma skin carcinomainsitu uterine cervix , unless tumor treat curative intent 2 year prior study entry . Receipt 3 prior regimen chemotherapy . Chemotherapy radiotherapy within 4 week ( 6 week nitrosoureas mitomycin C ) prior baseline . Receipt radiotherapy &gt; 25 % bone marrow . Major surgery within 4 week prior baseline . Concomitant treatment , anticipate use , pharmaceutical herbal agent potent inhibitor inducer cytochrome P450 enzymes unless approve Sponsor . Uncontrolled intercurrent illness would jeopardize patient safety , interfere objective protocol , limit patient compliance study requirement , determine Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>